BMS-986326

N/A

Report date: 2026/04/20 20:01:59

Base Information

Drug NameBMS-986326
Drug Alias NameBMS-986326
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 receptor alpha chain antagonists
TargetsInterleukin-2 receptor alpha chain
Therapy Area/IndicationsDermatitis, AtopicLupus Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[11
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicLupus Vulgaris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A